Skip to main content
OpenTrials

Clinical trial condition

Tumors

Explore clinical trials studying Tumors. Study availability and eligibility vary by location and protocol.

110 public trials 6 recruiting studies
Refine in advanced search Browse all conditions

Tumors trial results

Completed

A Multi-Center, Open-Label Study of Surufatinib (HMPL-012) in Patients With Advanced Solid Tumors

NCT02549937

Conditions
Adenocarcinoma, Carcinoid Tumor, Carcinoma, +12 more
Locations
  • City of Hope Comprehensive Cancer Center Los Angeles, California, United States
  • Rocky Mountain Cancer Center Denver, Colorado, United States
  • SCRI at HealthONE Denver, Colorado, United States
  • Florida Cancer Specialists Sarasota, Florida, United States
View Trial Details
Completed

A Study of the Safety and Pharmacokinetics of AGS-22M6E in Subjects With Malignant Solid Tumors That Express Nectin-4

NCT01409135

Conditions
Medical Oncology, Neoplasms, Tumors
Locations
  • UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States
  • University of Colorado, Denver-Aurora Aurora, Colorado, United States
  • Emory University Atlanta, Georgia, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details
Completed

A Trial of Lenvatinib (E7080) Plus Pembrolizumab in Participants With Selected Solid Tumors

NCT02501096

Conditions
Neoplasms, Tumors
Locations
  • Alaska Clinical Research Center Anchorage, Alaska, United States
  • Arizona Oncology Associates Oro Valley, Arizona, United States
  • Arizona Oncology Associates, PC - HOPE, Site #1 Tucson, Arizona, United States
  • Arizona Oncology Associates, PC - HOPE, Site #2 Tucson, Arizona, United States
View all 64 locations
View Trial Details
Completed

Study of Lenvatinib in Children and Adolescents With Refractory or Relapsed Solid Malignancies and Young Adults With Osteosarcoma

NCT02432274

Conditions
Differentiated Thyroid Cancer (DTC), Neoplasms, Neoplasms by Histologic Type, +7 more
Locations
  • Texas Children's Hospital Houston, Texas, United States
  • CHU Strasbourg - Hopital Hautepierre Strasbourg, Bas Rhin, France
  • Centre Oscar Lambret Lille Lille, Rhone, France
  • Centre Leon Berard Lyon, Rhone, France
View all 19 locations
View Trial Details
Completed

Safety Study of AMG 386 to Treat HER2-positive Locally Recurrent or Metastatic Breast Cancer

NCT00807859

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +16 more
Locations
  • Research Site Tucson, Arizona, United States
  • Research Site Boca Raton, Florida, United States
  • Research Site Iowa City, Iowa, United States
  • Research Site Boston, Massachusetts, United States
View all 23 locations
View Trial Details

Related conditions